Quick Answer
RXO, Inc. reported Operating Income Loss of -$79.00 million for the year ending 2025.
- RXO, Inc. showed a decrease of -41.1% in Operating Income Loss from 2024 to 2025.
- This data is from RXO, Inc.'s annual report (Form 10-K), filed with the SEC on February 9, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $38.00 million | Q1 2022: $51.00 million | Q2 2022: $58.00 million | Q3 2022: $15.00 million | Q1 2023: $5.00 million | Q2 2023: $14.00 million | Q3 2023: $6.00 million | Q1 2024: -$12.00 million | Q2 2024: $0.00 | Q3 2024: -$20.00 million | Q1 2025: -$30.00 million | Q2 2025: $0.00 | Q3 2025: -$7.00 million.
- Over the full 6 years of available data (2020 to 2025), RXO, Inc.'s Operating Income Loss has declined by 231.7%.
- Historical annual values: Fiscal year 2025: -$79.00 million | Fiscal year 2024: -$56.00 million | Fiscal year 2023: $39.00 million | Fiscal year 2022: $123.00 million | Fiscal year 2021: $192.00 million | Fiscal year 2020: $60.00 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: